4//SEC Filing
Gunn George W 4
Accession 0001572426-17-000022
CIK 0001618561other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:25 PM ET
Size
7.7 KB
Accession
0001572426-17-000022
Insider Transaction Report
Form 4
Gunn George W
Director
Transactions
- Disposition to Issuer
Ordinary Shares
2017-07-31$6.72/sh−42,600$286,272→ 0 total - Disposition to Issuer
Restricted Share Units
2017-07-31$6.59/sh−1,500$9,893→ 0 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (1,500 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.
- [F2]This restricted share unit, which would have vested and become convertible as to 500 shares on each of 9/30/17, 12/31/17 and 3/31/18, in each case subject to payment of the nominal value per share of $0.125 to the Issuer within 30 days of vesting, was cancelled in the Acquisition in exchange for a cash payment equal to $9,892.50. This amount represents the difference between such nominal value per share and the $6.72 consideration per share payable in connection with in the Acquisition, multiplied by the number of shares issuable on conversion of the restricted share unit.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeother
Related Parties
1- filerCIK 0001639458
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 9:25 PM ET
- Size
- 7.7 KB